A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
IRVINE, Calif., Dec. 08, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that in research published in the journal Nature, Dr. Johan Auwerx showed that Alzheimer's...
A4M Senior Vice-President Joseph Maroon will give away signed copies of his book, "Square One, A Simple Guide to a Balanced Life" at the TRU NIAGEN™ booth IRVINE, Calif., Dec. 04, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated...
IRVINE, Calif., Nov. 29, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that its Chief Executive Officer and Co-Founder, Frank Jaksch will present at the 10th annual...
- Company Reports Third Quarter 2017 Revenue of $6.1 Million, Up 55% Compared to Last Year -- Continued Progress on Building a Consumer Products Platform Around TRU NIAGEN™- IRVINE, Calif., Nov. 09, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully...
Private Placement Led By High Profile Venture Capitalists and Strategic Investors IRVINE, Calif., Nov. 06, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that it has...
-Company Will Host Investor Conference Call on Thursday, November 9, 2017- IRVINE, Calif., Nov. 02, 2017 -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that it plans on...